Research Unit, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain; Networked Biomedical Research Centre for Liver and Digestive Diseases (CIBEREHD), Madrid, Spain; Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain.
Department of Oncology, Hospital de Mataró, Consorci Sanitari del Maresme, Mataró, Barcelona, Spain.
Public Health. 2024 Dec;237:14-21. doi: 10.1016/j.puhe.2024.09.016. Epub 2024 Sep 23.
Knowledge of frailty prevalence and incidence trends over time is essential for planning the necessary health and social resources. The objective of this study was to assess frailty prevalence, incidence, reversibility and mortality rates, and trends for the population aged ≥65 years in Catalonia over the period 2017-2021.
Longitudinal epidemiological study.
An observational longitudinal 5-year study (1 January 2017 to 31 December 2021) of the population aged ≥65 years in Catalonia (approximately 1.5 million individuals) was performed using retrospectively collected data from different health databases. Frailty status was evaluated using the electronic Screening Index of Frailty (e-SIF) and categorised as robust, pre-frail, moderately frail or severely frail.
Standardised frailty prevalence rates were 10.5 % (2017), 11.8 % (2018), 13.1 % (2019), 12.9 % (2020) and 14.3 % (2021) [p-value for trend = 0.010]. Standardised frailty incidence rates per 1000 non-frail persons/year were 35 (2018), 36 (2019), 28 (2020) and 33 (2021) [p-value for trend = 0.492]. Both prevalence and incidence were higher in women and increased with age. Standardised frailty reversibility rates per 1000 frail persons/year were 123 (2018), 108 (2019) and 121 (2020) [p-value for trend = 0.406], and decreased with age. Standardised mortality rates for frail individuals per 1000 frail persons/year were 93 (2018), 84 (2019) and 110 (2020) [p-value for trend = 0.555], and increased with frailty severity.
Frailty prevalence in Catalonia increased by 36 % between 2017 and 2021; however, no clear trend was evident for frailty incidence and reversibility, while results for mortality were likely to have been influenced by the COVID-19 pandemic.
了解虚弱的流行率和随时间推移的发病率趋势对于规划必要的卫生和社会资源至关重要。本研究的目的是评估 2017-2021 年间加泰罗尼亚地区≥65 岁人群的虚弱流行率、发病率、可逆转性和死亡率以及趋势。
纵向流行病学研究。
使用从不同健康数据库中回顾性收集的数据，对加泰罗尼亚地区≥65 岁人群（约 150 万人）进行了一项为期 5 年的观察性纵向研究（2017 年 1 月 1 日至 2021 年 12 月 31 日）。使用电子虚弱筛查指数（e-SIF）评估虚弱状态，并将其分类为强壮、虚弱前期、中度虚弱或严重虚弱。
标准化虚弱流行率分别为 10.5%（2017 年）、11.8%（2018 年）、13.1%（2019 年）、12.9%（2020 年）和 14.3%（2021 年）[趋势的 p 值=0.010]。每 1000 名非虚弱个体/年的标准化虚弱发病率为 35（2018 年）、36（2019 年）、28（2020 年）和 33（2021 年）[趋势的 p 值=0.492]。女性的虚弱流行率和发病率均较高，且随年龄增长而增加。每 1000 名虚弱个体/年的标准化虚弱可逆转率分别为 123（2018 年）、108（2019 年）和 121（2020 年）[趋势的 p 值=0.406]，且随年龄增长而降低。每 1000 名虚弱个体/年的虚弱个体标准化死亡率分别为 93（2018 年）、84（2019 年）和 110（2020 年）[趋势的 p 值=0.555]，且随虚弱严重程度增加而增加。
2017-2021 年间，加泰罗尼亚地区的虚弱流行率增加了 36%；然而，虚弱的发病率和可逆转性没有明显的趋势，而死亡率的结果可能受到 COVID-19 大流行的影响。
Zotero 插件